![Christopher Lai](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher Lai
Director Ejecutivo en METiS Therapeutics, Inc. .
Cargos activos de Christopher Lai
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
METiS Therapeutics, Inc.
![]() METiS Therapeutics, Inc. BiotechnologyHealth Technology METiS Therapeutics, Inc. is a discovery technology and therapeutics company that aims to develop best-in-class drug assets across various therapeutic areas. The company is based in Cambridge, MA and has subsidiaries in the United States and China. Joining the team offers an exciting career in therapeutics for AI drug discovery. METiS Therapeutics was founded by Christopher Lai and Wenshou Wang, with Christopher Lai serving as the CEO since incorporation. | Director Ejecutivo | - | - |
Fundador | - | - | |
Metis Pharmaceuticals
![]() Metis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of METiS Therapeutics, Inc., Metis Pharmaceuticals is a Chinese company that focuses on independent innovation and research and development capabilities in the pharmaceutical industry. The company is based in Hangzhou, China. The company aims to accelerate the pace of innovation and promote high-quality industry development. Dishita Pharmaceuticals, the parent company, supports Metis Pharmaceuticals in developing more effective treatment drugs for patients. It was founded in 2019 by Christopher Lai, who has been the CEO since then. | Director/Miembro de la Junta | 01/01/2019 | - |
Director Ejecutivo | 01/01/2019 | - | |
Fundador | 01/01/2019 | - |
Historial de carrera de Christopher Lai
Antiguos cargos conocidos de Christopher Lai.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AquaFresco, Inc.
![]() AquaFresco, Inc. Industrial MachineryProducer Manufacturing AquaFresco, Inc. provides wastewater recycle system services. The firm serves in the area of hotels, commercial laundry facilities, car-wash, industrial cleaning, and other wastewater treatment process markets. The company was founded by Sasha Huang, Chris Lai and Alina Rwei in 2015 and is headquartered in Jamaica Plain, MA. | Director Técnico/Científico/I+D | 01/01/2015 | - |
Fundador | 01/01/2015 | - |
Estadísticas
Internacional
Estados Unidos | 3 |
China | 2 |
Operativa
Founder | 3 |
Chief Executive Officer | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Health Technology | 3 |
Producer Manufacturing | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
AquaFresco, Inc.
![]() AquaFresco, Inc. Industrial MachineryProducer Manufacturing AquaFresco, Inc. provides wastewater recycle system services. The firm serves in the area of hotels, commercial laundry facilities, car-wash, industrial cleaning, and other wastewater treatment process markets. The company was founded by Sasha Huang, Chris Lai and Alina Rwei in 2015 and is headquartered in Jamaica Plain, MA. | Producer Manufacturing |
METiS Therapeutics, Inc.
![]() METiS Therapeutics, Inc. BiotechnologyHealth Technology METiS Therapeutics, Inc. is a discovery technology and therapeutics company that aims to develop best-in-class drug assets across various therapeutic areas. The company is based in Cambridge, MA and has subsidiaries in the United States and China. Joining the team offers an exciting career in therapeutics for AI drug discovery. METiS Therapeutics was founded by Christopher Lai and Wenshou Wang, with Christopher Lai serving as the CEO since incorporation. | Health Technology |
Metis Pharmaceuticals
![]() Metis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of METiS Therapeutics, Inc., Metis Pharmaceuticals is a Chinese company that focuses on independent innovation and research and development capabilities in the pharmaceutical industry. The company is based in Hangzhou, China. The company aims to accelerate the pace of innovation and promote high-quality industry development. Dishita Pharmaceuticals, the parent company, supports Metis Pharmaceuticals in developing more effective treatment drugs for patients. It was founded in 2019 by Christopher Lai, who has been the CEO since then. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Lai
- Experiencia